University Cancer & Blood Center

Clinical Trials for Pancreatic Cancer

CA126-015

Phase 1/2 Open-label Study of BMS-986466 in Combination With Adagrasib With or Without Cetuximab in Participants With KRAS G12C-mutant Advanced Solid Tumors. View details.

CG-745-2-08

A Phase 1b/2, Dose-escalation, Randomized, Multicenter Study of Maintenance Ivaltinostat Plus Capecitabine or Capecitabine in Patients With Metastatic Pancreatic Adenocarcinoma Whose Disease Has Not Progressed on FOLFIRINOX. View Details.

Krystal-1

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients With Advanced Solid Tumors With KRAS G12C Mutation. View Details.


Learn more about Pancreatic Cancer >

Our Affiliations

The Cancer FoundationNCIACHC Accredited

We’re Here to Help! Click Below to Get Started

Contact Us Now